US$ 26.13
retatrutide news october 2025 A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Retatrutide, a new weight loss
Description
Sizemore G, Lucke-Wold B, Small C
With a background in both traditional healthcare and start-ups, she brings a culturally inclusive, patient-centered approach from early diagnosis to long-term management

Navarria, A
What Is Peptide Therapy

Products like Ozempic and Wegovy are GLP-1 drugs, named after the hormone they mimic and which is activated by food intake

As research continues and regulatory approvals progress, it could play an important role in the future of obesity care in India and globally.
